fda glp-1 compounding enforcement news october 2025 Diabetes advocacy group discourages use of compounded drugs September 15, 2025: Telehealth company

Menstrual irregularities An analysis of over 410,000 social media posts (self-reported anecdotal evidence) by people taking semaglutide or tirzepatide found that menstrual irregularities were among the most commonly self-reported side effects not well captured in clinical trial data, suggesting this may be more prevalent than official labelling indicates

Draelos ZD

Avoid straining when trying to pass a stool, as this puts greater pressure on the veins in your lower rectum

(PubMed) Heart Protection Study Collaborative Group

MDA-MB-231 human breast cancer cells and WM266.4 human melanoma cells are also kind gifts from Prof